Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn J Barst

Showing results (101-110 of 137) with videos related to

Pageof 14
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 28, 2008
Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertensionErika B Rosenzweig, Jane H Morse, James A Knowles, et al.
Annals of the Rheumatic Diseases|May 3, 2007
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue diseaseReda E Girgis, Adaani E Frost, Nicholas S Hill, et al.
Journal of the American College of Cardiology|December 21, 2013
Pediatric pulmonary hypertensionD Dunbar Ivy, Steven H Abman, Robyn J Barst, et al.
British Journal of Clinical Pharmacology|December 17, 2009
Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 studyMaurice Beghetti, Sheila G Haworth, Damien Bonnet, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[Pediatric pulmonary hypertension]D Dunbar Ivy, Steven H Abman, Robyn J Barst, et al.
American Journal of Respiratory and Critical Care Medicine|November 25, 2003
Sitaxsentan therapy for pulmonary arterial hypertensionRobyn J Barst, David Langleben, Adaani Frost, et al.
Chest|June 19, 2010
The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary RegistriesAdaani E Frost, David B Badesch, Robyn J Barst, et al.
Circulation|June 30, 2010
Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)Raymond L Benza, Dave P Miller, Mardi Gomberg-Maitland, et al.
Chest|October 17, 2014
Hospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational studyRobert P Frantz, Robert J Schilz, Murali M Chakinala, et al.
Journal of the American College of Cardiology|June 25, 2003
Beraprost therapy for pulmonary arterial hypertensionRobyn J Barst, Michael McGoon, Vallerie McLaughlin, et al.
Pageof 14

Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 28, 2008
Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertensionErika B Rosenzweig, Jane H Morse, James A Knowles, et al.
Annals of the Rheumatic Diseases|May 3, 2007
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue diseaseReda E Girgis, Adaani E Frost, Nicholas S Hill, et al.
Journal of the American College of Cardiology|December 21, 2013
Pediatric pulmonary hypertensionD Dunbar Ivy, Steven H Abman, Robyn J Barst, et al.
British Journal of Clinical Pharmacology|December 17, 2009
Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 studyMaurice Beghetti, Sheila G Haworth, Damien Bonnet, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[Pediatric pulmonary hypertension]D Dunbar Ivy, Steven H Abman, Robyn J Barst, et al.
American Journal of Respiratory and Critical Care Medicine|November 25, 2003
Sitaxsentan therapy for pulmonary arterial hypertensionRobyn J Barst, David Langleben, Adaani Frost, et al.
Chest|June 19, 2010
The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary RegistriesAdaani E Frost, David B Badesch, Robyn J Barst, et al.
Circulation|June 30, 2010
Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)Raymond L Benza, Dave P Miller, Mardi Gomberg-Maitland, et al.
Chest|October 17, 2014
Hospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational studyRobert P Frantz, Robert J Schilz, Murali M Chakinala, et al.
Journal of the American College of Cardiology|June 25, 2003
Beraprost therapy for pulmonary arterial hypertensionRobyn J Barst, Michael McGoon, Vallerie McLaughlin, et al.
Pageof 14